Association of Serum Triglyceride Levels with Severity in Acute Pancreatitis: Results from an International, Multicenter Cohort Study.


Journal

Digestion
ISSN: 1421-9867
Titre abrégé: Digestion
Pays: Switzerland
ID NLM: 0150472

Informations de publication

Date de publication:
2021
Historique:
received: 28 04 2020
accepted: 30 10 2020
pubmed: 22 1 2021
medline: 4 9 2021
entrez: 21 1 2021
Statut: ppublish

Résumé

Hypertriglyceridemia (HTG) is considered within the top 5 etiologies in acute pancreatitis (AP), but the association of serum triglyceride (TG) levels with the clinical course of AP remains controversial. This study aims to examine the effect of TG levels on severity of AP. Patients were enrolled prospectively through APPRENTICE. High TG levels were defined based on the Endocrine Society Clinical Practice Guidelines. HTG was categorized as mild (serum TG levels 150-199 mg/dL), moderate (200-999 mg/dL), severe (1,000-1,999 mg/dL), and very severe (≥2,000 mg/dL). Severity of AP was based on the revised Atlanta classification criteria. Early TG levels were measured in 764 subjects and found elevated in 342 (120 with mild; 176, moderate; and 46, severe/very severe HTG). Patients with increased TG levels were younger (age ≥60, 16.7 vs. 30.3%), more likely to be male (66.1 vs. 51.2%), with more frequent alcohol use (62.8 vs. 50.7%), and diabetes mellitus (30.2 vs. 12.3%; all p ≤ 0.005). Severe AP (24.9 vs. 10.0%), ICU admission (32.5 vs. 19.7%), and mortality (5.3 vs. 1.7%; all p ≤ 0.005) were more frequently seen in patients with elevated TG levels. Based on multivariable analysis, elevated TG levels were independently associated with severe AP (p < 0.05). This large multicenter study confirms that elevated TG levels are associated with severe disease regardless of AP etiology.

Sections du résumé

BACKGROUND BACKGROUND
Hypertriglyceridemia (HTG) is considered within the top 5 etiologies in acute pancreatitis (AP), but the association of serum triglyceride (TG) levels with the clinical course of AP remains controversial.
OBJECTIVES OBJECTIVE
This study aims to examine the effect of TG levels on severity of AP.
METHODS METHODS
Patients were enrolled prospectively through APPRENTICE. High TG levels were defined based on the Endocrine Society Clinical Practice Guidelines. HTG was categorized as mild (serum TG levels 150-199 mg/dL), moderate (200-999 mg/dL), severe (1,000-1,999 mg/dL), and very severe (≥2,000 mg/dL). Severity of AP was based on the revised Atlanta classification criteria.
RESULTS RESULTS
Early TG levels were measured in 764 subjects and found elevated in 342 (120 with mild; 176, moderate; and 46, severe/very severe HTG). Patients with increased TG levels were younger (age ≥60, 16.7 vs. 30.3%), more likely to be male (66.1 vs. 51.2%), with more frequent alcohol use (62.8 vs. 50.7%), and diabetes mellitus (30.2 vs. 12.3%; all p ≤ 0.005). Severe AP (24.9 vs. 10.0%), ICU admission (32.5 vs. 19.7%), and mortality (5.3 vs. 1.7%; all p ≤ 0.005) were more frequently seen in patients with elevated TG levels. Based on multivariable analysis, elevated TG levels were independently associated with severe AP (p < 0.05).
CONCLUSION CONCLUSIONS
This large multicenter study confirms that elevated TG levels are associated with severe disease regardless of AP etiology.

Identifiants

pubmed: 33477149
pii: 000512682
doi: 10.1159/000512682
pmc: PMC9191264
mid: NIHMS1811301
doi:

Substances chimiques

Triglycerides 0

Types de publication

Multicenter Study News

Langues

eng

Sous-ensembles de citation

IM

Pagination

809-813

Subventions

Organisme : NCI NIH HHS
ID : T32 CA186873
Pays : United States

Informations de copyright

© 2021 S. Karger AG, Basel.

Références

J Clin Endocrinol Metab. 2012 Sep;97(9):2969-89
pubmed: 22962670
Gut. 2013 Jan;62(1):102-11
pubmed: 23100216
Ann Gastroenterol. 2017;30(1):106-113
pubmed: 28042246
United European Gastroenterol J. 2018 Jun;6(5):649-655
pubmed: 30083325
Eur J Intern Med. 2014 Oct;25(8):689-94
pubmed: 25269432
Am J Gastroenterol. 2015 Oct;110(10):1497-503
pubmed: 26323188
Int J Clin Pract. 2006 Feb;60(2):156-9
pubmed: 16451286
Pancreatology. 2020 Apr;20(3):325-330
pubmed: 32107193
Am J Gastroenterol. 2012 Nov;107(11):1730-9
pubmed: 22929760

Auteurs

Ioannis Pothoulakis (I)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
MedStar Washington Hospital Center, Washington, District of Columbia, USA.

Pedram Paragomi (P)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Marie Tuft (M)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Ali Lahooti (A)

Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

Livia Archibugi (L)

Pancreato-Biliary Endoscopy and Endosonography Division, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute IRCCS, Milan, Italy.
Digestive and Liver Disease Unit, Sant Andrea Hospital, Rome, Italy.

Gabriele Capurso (G)

Pancreato-Biliary Endoscopy and Endosonography Division, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute IRCCS, Milan, Italy.
Digestive and Liver Disease Unit, Sant Andrea Hospital, Rome, Italy.

Georgios I Papachristou (GI)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA, georgios.papachristou@osumc.edu.
Ohio State University Wexner Medical Center, Columbus, Ohio, USA, georgios.papachristou@osumc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH